NKGN

NKGen Biotech, Inc. Common Stock
NKGN

Overview Fund Activity
Delisted

NKGN was delisted on the 4th of March, 2025.

Back to rankings

53 hedge funds and large institutions have $143M invested in NKGen Biotech, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.

Holders
53
Holders Change
+5
Holders Change %
+10.42%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MF
1
Magnetar Financial
Illinois
$9.75M
2
BNP Paribas Financial Markets
2
BNP Paribas Financial Markets
France
$7.33M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$5.75M
4
MP
4
Mangrove Partners
Connecticut
$1.79M
5
GF
5
Gabelli Funds
New York
$2.73M

Top Sellers

1
KC
1
Kepos Capital
New York
$0
2
Parallax Volatility Advisers
2
Parallax Volatility Advisers
California
$0
3
CL
3
CSS LLC
Illinois
$1.55M
4
FBCM
4
Fort Baker Capital Management
California
$1.96M
5
UOC
5
UBS O'Connor
Illinois
$3.12M
Name Market Value Shares Shares
Change 		Shares
Change %
RCM
51
Robinson Capital Management
Michigan
$88K 9,044 +9,044 New
UBS Group
52
UBS Group
Switzerland
$17K 1,740 +1,740 New
AA
53
Ancora Advisors
Ohio
$10K 1,000 – –
KC
54
Kepos Capital
New York
– – -525,000 Closed
Parallax Volatility Advisers
55
Parallax Volatility Advisers
California
– – -164,071 Closed
OMC
56
Old Mission Capital
Illinois
– – -11,485 Closed
CFGS
57
Concourse Financial Group Securities
Alabama
– – – –
1 2
3